PATENT CLAIM ANALYSIS

Application Number: 16166357
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "458000"]

Abstract:
The present invention relates to the use of mixtures of vitamin E and polyunsaturated fatty acids (PUFAs) as agents for the prevention, control and/or treatment of conditions associated with excessive fat accumulation in the liver which is not caused by alcohol abuse. This includes prevention, control and/or treatment of non-alcoholic steatosis in the liver—known as non-alcoholic fatty liver disease (NAFLD)—and/or non-alcoholic steatohepatitis (NASH) in a subject in need thereof. In particular, the present invention relates to the use of such compounds comprising vitamin E acetate and DHA EE as active ingredients in the manufacture of medicaments for the prevention, control and/or treatment of conditions related to NAFLD.

Claim (Index 8):
A method for the treatment or prevention of diseases associated with non-alcoholic fat accumulation in the liver, which comprises administering to the subject in need thereof an effective amount of DHA EE and vitamin E acetate.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 97.0
- Lexical Diversity: 1.75362
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14899101', '14905520', '15102136', '15509766', '12383241']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7455172752154987
- 35 USC 102 Novelty (BERT): 0.4939723601872783
- Combined Prediction Score: 0.7203627837126767
- Mean Citation Score: 182.165394
- Max Citation Score: 183.52545
- Similarity Product: 119.97808971276284

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test